Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
148.41B
Market cap148.41B
Price-Earnings ratio
19.93
Price-Earnings ratio19.93
Dividend yield
6.62%
Dividend yield6.62%
Average volume
35.31M
Average volume35.31M
High today
$26.13
High today$26.13
Low today
$25.70
Low today$25.70
Open price
$26.06
Open price$26.06
Volume
32.82M
Volume32.82M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $26.03. The company's market cap stands at 148.41B, with a P/E ratio of 19.93 and a dividend yield of 6.62%.

On 2026-06-16, Pfizer(PFE) stock moved within a range of $25.70 to $26.13. With shares now at $26.03, the stock is trading +1.3% above its intraday low and -0.4% below the session's peak.

Trading activity shows a volume of 32.82M, compared to an average daily volume of 35.31M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

PFE News

TipRanks 55m
Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

24/7 Wall St. 4h
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? By David Moadel Published Jun 16, 3:21PM EDT Quick Read Moderna...

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
TipRanks 6h
Option traders moderately bearish in Pfizer with shares up 0.29%

Option traders moderately bearish in Pfizer (PFE), with shares up 8c, or 0.29%, near $26.07. Options volume roughly in line with average with 74k contracts trad...

Analyst ratings

59%

of 29 ratings
Buy
34.5%
Hold
58.6%
Sell
6.9%

More PFE News

Nasdaq 1d
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth

Key Points By 2029, Pfizer CEO Albert Bourla believes the company may return to high-single-digit growth. Recent settlements have pushed back the patent cliff...

Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
TipRanks 3d
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Introducing TipRanks MCP for Agents Deliver institut...

Simply Wall St 4d
Pfizer Stock Valuation Check As Modest Recent Gains Meet Mixed Multi Year Returns

Advertisement What Pfizer (PFE) investors can see in the recent performance Pfizer (PFE) has seen its stock edge up around 0.2% in the past day and about 0.7%...

Pfizer Stock Valuation Check As Modest Recent Gains Meet Mixed Multi Year Returns
TipRanks 4d
Pfizer Targets Gastric Cancer Growth With New PF-08634404 Combo Trial

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 2/3 trial called “A PHASE 2/3 INTERVENTIONAL STUDY O...

24/7 Wall St. 4d
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Eli Lilly (NYSE:LL...

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
24/7 Wall St. 5d
This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . CEO Albert Bourla...

This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees
24/7 Wall St. 5d
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25 By Alex Sirois Published Jun 11, 2:23PM EDT Quick Read Pfizer...

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.